REVENUE RECOGNITION AND RELATED ALLOWANCES (Tables)

6 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation of revenue and revenue recognized

All revenue recognized in the accompanying unaudited interim condensed consolidated statements of operations is considered to be revenue from contracts with customers. The following table depicts the disaggregation of revenue:

	Three Months Ended				Six Months Ended
Products and Services	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
(in thousands)
Sales of generic pharmaceutical products	$	63,317	$	49,863	$	127,030	$	98,970
Sales of established brand pharmaceutical products, royalties, and other pharmaceutical services	28,926		13,790		55,669		27,868
Sales of rare disease pharmaceutical products	24,304		10,202		40,634		11,494
Total net revenues	$	116,547	$	73,855	$	223,333	$	138,332

	Three Months Ended				Six Months Ended
Timing of Revenue Recognition	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
(in thousands)
Performance obligations transferred at a point in time	$	116,547	$	73,324	$	222,958	$	137,235
Performance obligations transferred over time	—		531		375		1,097
Total	$	116,547	$	73,855	$	223,333	$	138,332

Schedule of accruals and allowances

The following table summarizes activity in the condensed consolidated balance sheets for accruals and allowances for the six months ended June 30, 2023 and 2022, respectively:

	Accruals for Chargebacks, Returns, and Other Allowances
(in thousands)	Chargebacks		Government Rebates		Returns		Administrative Fees and Other Rebates		Prompt Payment Discounts
Balance at December 31, 2021	$	94,066	$	5,492	$	35,831	$	13,100	$	4,642
Accruals/Adjustments	320,191		9,356		15,057		20,701		10,494
Credits Taken Against Reserve	(274,714)		(5,408)		(15,989)		(19,283)		(8,938)
Balance at June 30, 2022 (1)	$	139,543	$	9,440	$	34,899	$	14,518	$	6,198
Balance at December 31, 2022	$	148,562	$	10,872	$	33,399	$	9,442	$	6,488
Accruals/Adjustments	290,826		11,100		5,995		25,606		11,028
Credits Taken Against Reserve	(362,253)		(10,001)		(9,596)		(25,177)		(12,653)
Balance at June 30, 2023 (1)	$	77,135	$	11,971	$	29,798	$	9,871	$	4,863

______________________________________________

(1)Chargebacks and Prompt Payment Discounts are included as an offset to accounts receivable in the unaudited interim condensed consolidated balance sheets. Administrative Fees and Other Rebates are included as an offset to accounts receivable or as accrued expenses and other in the unaudited interim condensed consolidated balance sheets. Returns are included in returned goods reserve in the unaudited interim condensed consolidated balance sheets. Government Rebates are included in accrued government rebates in the unaudited interim condensed consolidated balance sheets.

Schedule of customer concentration

The three customers represent the total percentage of net revenues as follows:

	Three Months Ended				Six Months Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Customer 1	32	%	23	%	32	%	27	%
Customer 2	14	%	19	%	14	%	19	%
Customer 3	13	%	15	%	13	%	14	%
Customer 4	10	%	6	%	9	%	4	%